Sunshine Biopharma Inc. -27SBFMWPreferred / convertible
13F holders, Q2 2025 (June 30)3holders
0new positions
0sold out
1famous investor
$0.24avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Sunshine Biopharma Inc. -27 (SBFMW) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were UBS Group AG ($6K), Citadel Advisors ($5K) and Clear Street LLC ($27). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Sunshine Biopharma Inc. -27
- CUSIP
- 867781502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 15,292 shares sold, net −15,292 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| UBS Group AG | — | Reduce -17.4% | 24,569 | $6K |
| Citadel Advisors | — | Reduce -33.2% | 20,415 | $5K |
| Clear Street LLC | — | No change | 94 | $27 |
"% of holder's portfolio" is SBFMW's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. -27 the manager owns.